{'fraction_non_alphanumeric': 0.0758082497212932, 'fraction_numerical': 0.03901895206243032, 'mean_word_length': 4.907894736842105, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
X-ray crystal structure and conformation of a spin-labeled acetylcholine, DL-4-[N,N-dimethyl-n-(ethan-2'-olacetate)amino]-2,2,6,6-tetramethylpiperidine-1-oxyliodide.

The detailed molecular geometry of the title compound, a muscarinic blocking agent, has been established by single-crystal X-ray analysis. Crystals are orthorhombic, space group Pbca, a = 18.00(1), b = 11.42(1), c = 18.42(1) A,Z = 8. The structure was solved by the heavy-atom method, and atomic parameters were refined by full-matrix, least-squares calculations to R 0.049 over 1082 statistically significant reflections from diffractometer measurements. Comparison of the results with those for known muscarinic agents revealed that whereas the O-C-C-N+ torsion angle at 78° is similar to those in other potent muscarinic agents, the C-O (ester)-C-C torsion angle at 99° lies outside the range predicted for muscarinic agonists.